Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.
Espinoza SE, Wang CP, Tripathy D, Clement SC, Schwenke DC, Banerji MA, Bray GA, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Stentz FB, Reaven PD, DeFronzo RA, Musi N.
Espinoza SE, et al.
Age (Dordr). 2016 Dec;38(5-6):485-493. doi: 10.1007/s11357-016-9946-6. Epub 2016 Sep 1.
Age (Dordr). 2016.
PMID: 27585671
Free PMC article.
Clinical Trial.